Clinical Efficacy of Polymyxin Monotherapy versus Nonvalidated Polymyxin Combination Therapy versus Validated Polymyxin Combination Therapy in Extensively Drug-Resistant Gram-Negative Bacillus Infections

Polymyxins have emerged as a last-resort treatment of extensively drug-resistant (XDR) Gram-negative Bacillus (GNB) infections, which present a growing threat. Individualized polymyxin-based antibiotic combinations selected on the basis of the results of in vitro combination testing may be required...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:Antimicrob Agents Chemother
Κύριοι συγγραφείς: Cai, Bingxuan, Cai, Yiying, Liew, Yi Xin, Chua, Nathalie Grace, Teo, Jocelyn Qi-Min, Lim, Tze-Peng, Kurup, Asok, Ee, Pui Lai Rachel, Tan, Thuan Tong, Lee, Winnie, Kwa, Andrea Lay-Hoon
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: American Society for Microbiology 2016
Θέματα:
Clinical Therapeutics
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4914661/
https://ncbi.nlm.nih.gov/pubmed/27090177
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.03064-15
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια